Bayer Profile Banner
Bayer AG Profile
Bayer AG

@Bayer

Followers
181K
Following
7K
Media
5K
Statuses
12K

Health for All, Hunger for None. That’s what drives us at Bayer.

Leverkusen, Germany
Joined April 2010
Don't wanna be here? Send us removal request.
@Bayer
Bayer AG
11 days
#News: EU approval for extended treatment intervals in retinal diseases offers hope for better management of eye conditions like neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME). Learn more:
3
2
13
@Bayer
Bayer AG
13 days
RT @MicheleZanini: Flattening organizations is everywhere in the news, but it's usually just cost-cutting dressed up as transformation. As….
0
5
0
@Bayer
Bayer AG
21 days
#TeamBayer is proud to announce the submission of a New Drug Application to the US Food and Drug Administration (FDA) for a low dose #MRI contrast agent. Find out more:
5
5
15
@Bayer
Bayer AG
29 days
RT @googlecloud: #DYK, data agents edition: @Bayer built a data agent that uses #generativeAI in BigQuery to predict flu outbreaks. It comb….
0
10
0
@Bayer
Bayer AG
1 month
Tokom proteklih godina došlo je do značajnog povećanja cena kvalitetnih sirovina, pakovanja i transporta, ali i faktori poput carinskih taksi, marži i lokalnih tržišnih uslova mogu uticati na konačnu cenu proizvoda. Hvala vam na vašem interesovanju! (2/2).
2
0
0
@Bayer
Bayer AG
1 month
Bayer to present for the first time detailed data from the first pivotal PIII study for menopause symptoms in women with breast cancer at ASCO 2025 which have been also published in NEJM: #TeamBayer #HealthForAll #HungerForNone
3
1
13
@Bayer
Bayer AG
2 months
#NEWS: EU recommendation for an eye drug with long dosing intervals for the treatment of (wet) age-related macular degeneration and diabetic macular edema. Learn more:
1
6
14
@Bayer
Bayer AG
2 months
Earlier today, we published our Q1 2025 results. Our CEO Bill Anderson provides a 90-second overview of the figures from the first quarter and a look into the rest of 2025:
8
10
22
@Bayer
Bayer AG
2 months
First-quarter performance: Bayer confirms 2025 targets after solid start to the year. Check our press release for more information:
Tweet media one
5
6
25
@Bayer
Bayer AG
2 months
#NEWS: Bayer submits a marketing authorization application in Japan for an eye medication with long dosing intervals for the treatment of patients with macular edema following retinal vein occlusion. Learn more:
7
8
10
@Bayer
Bayer AG
3 months
+++ A landmark launch year for Bayer Pharmaceuticals +++ . Today, at our annual Pharma Media Day, we unveiled key advancements in our long-term growth strategy. #TeamBayer #PharmaMediaDay #PMD25
Tweet media one
Tweet media two
Tweet media three
Tweet media four
6
13
17
@Bayer
Bayer AG
4 months
Ending hunger is central to our mission at Bayer. Our CEO, Bill Anderson, and Zambia's President, Hakainde Hichilema, have opened our new maize seed facility in Zambia 🇿🇲 , which aims to improve #foodsecurity for 30 million people and empower smallholder farmers across Africa.
@HHichilema
Hakainde Hichilema
4 months
There is no agriculture without good seed. @Bayer is opening the way for good and high quality seed at their seed facility at Itaba farm in Kabwe. We spent this morning and part of the afternoon inspecting it and we officially commissioned the plant.
Tweet media one
Tweet media two
5
12
19
@Bayer
Bayer AG
4 months
Earlier today, we published our Full Year 2024 results. CEO Bill Anderson provides a 90-second overview of the figures from 2024 and a look ahead to 2025:
11
14
34
@Bayer
Bayer AG
4 months
Bayer achieved its adjusted guidance for the Full Year 2024 and takes decisive action to tackle challenges in 2025. See more in our latest press release:
Tweet media one
3
9
17
@Bayer
Bayer AG
4 months
RT @FortuneMagazine: .@Bayer CEO Bill Anderson has infused a startup feel into the 161-year-old German pharmaceutical firm. On this week's….
0
4
0
@Bayer
Bayer AG
4 months
The burden of neurological disorders impacts millions of patients and is set to rise during the next decades. We are excited to present results of a pivotal Phase III study in MRI focusing on detecting pathologies of the central nervous system:
5
6
16
@Bayer
Bayer AG
5 months
By 2050, climate change could cut farmers' harvests by 17% and arable land by 20%. #TeamBayer is tackling this with our Crop Key approach, using biology, chemistry, and #AI to target pests effectively and safely. #RegenerativeAgriculture #CropProtection
8
12
22
@Bayer
Bayer AG
5 months
#News: Investigational Gene therapy for Parkinson’s disease receives RMAT designation. We are proud to be the first company granted RMAT designation both in gene therapy with @ask_bio and cell therapy with @BlueRockTx. Learn more:
5
11
26
@Bayer
Bayer AG
5 months
#News: New treatment option for patients with transthyretin amyloid cardiomyopathy (ATTR-CM) receives EU approval. Learn more:
8
8
15
@Bayer
Bayer AG
5 months
#NEWS: Bayer submitted EU-application for treatment intervals of up to 6-months in wet age-related macular degeneration and diabetic macular edema. Learn more:
4
5
11